Results 21 to 30 of about 58,257 (262)
Tumour microenvironment has an important effect on the progression of cutaneous T-cell lymphomas. Using PCR with sequence-specific primers, this study analysed single-nucleotide polymorphisms in the interleukin-17 genes of 150 patients with cutaneous T ...
Karol Kołkowski +5 more
doaj +1 more source
Accessibility and readability of online patient education on cutaneous lymphomasCapsule Summary
Background: Patients facing a cutaneous lymphoma diagnosis frequently turn to the internet for information but finding patient-accessible education may be a challenge.
Celine M. Schreidah, BS +5 more
doaj +1 more source
Secondary lymphomas of the skin
Skin can be primarily involved by a lymphoma or can be colonised by a systemic disease. Hence, two categories of lymphoma can be distinguished: the primary cutaneous lymphoma (PCL) and the systemic lymphoma that secondarily involves the skin, also known
Alessandro Pileri +3 more
doaj +1 more source
Therapeutic Efficacy of Etretinate on Cutaneous-type Adult T-cell Leukemia-Lymphoma
Cutaneous-type adult T-cell leukemia-lymphoma is treated with antiviral or skin-directed therapy. Medications that are used to treat skin lesions of cutaneous T-cell lymphomas are also used for the cutaneous-type adult T-cell leukemia-lymphoma ...
Kentaro Yonekura +5 more
doaj +1 more source
Pseudolymphomatous Folliculitis on the Nose
Pseudolymphomatous folliculitis (PLF), which sometimes mimicks cutaneous lymphoma, is a rare manifestation of cutaneous pseudolymphoma and cutaneous lymphoid hyperplasia.
Aya Kakizaki +4 more
doaj +1 more source
CD30-positive cutaneous lymphoma: report of four cases with an emphasis on clinicopathological correlations [PDF]
: The classification of cutaneous lymphomas is multidisciplinary and requires the correlation between clinical, histopathological, immunohistochemical, and molecular diagnostic elements. In this article, we present four different cases of CD30-positive T-
Thiago Jeunon de Sousa Vargas +2 more
doaj +2 more sources
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Cutaneous Lymphoma in a Tertiary Skin Hospital and Referral Centre in Nepal
Background: Primary cutaneous lymphomas are a distinct group of rare lymphoid neoplasms with absence of extracutaneous lymphomas at the time of presentation.
Ram Chandra Adhikari +3 more
doaj +1 more source
Rheumatologic Manifestations of Patients With Type B Insulin Resistance
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya +4 more
wiley +1 more source
Primary cutaneous B-cell lymphoma and chronic leg ulcers in a patient with type 2 diabetes
The incidences of type 2 diabetes mellitus and many cancers are rapidly increasing worldwide. Diabetes is a strong risk factor for some cancers (including lymphomas) and is also associated with adverse cancer outcomes. After gastrointestinal tract, the
Alessandro Mantovani +10 more
doaj +1 more source

